Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia

Area of Science:

• Pulmonary Medicine
• Neonatology
• Developmental Biology

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants, characterized by abnormal alveologenesis.
• Alveologenesis, the final stage of lung development, is critical for establishing adequate gas exchange surface area.
• This process involves complex interactions between lung interstitial, epithelial, and vascular cells.

Purpose of the Study:

• To review recent advancements in understanding the molecular mechanisms of alveologenesis.
• To identify key molecules and signaling pathways involved in lung development and their alterations in BPD.
• To explore potential therapeutic targets for BPD based on these molecular insights.

Main Methods:

• Review of recent scientific literature on alveologenesis and BPD.
• Identification of crucial structural, signaling, and remodeling molecules.
• Analysis of BPD-associated changes in molecule expression using clinical and animal models.

Main Results:

• Elastin deposition and various signaling molecules (e.g., PDGF, FGF, VEGF) are pivotal in lung wall development.
• BPD is associated with altered expression of these key molecules, particularly in signaling pathways.
• Studies in premature infants and animal models (baboons, lambs, rodents) confirm these molecular changes.

Conclusions:

• Understanding the molecular basis of alveolar development is crucial for BPD research.
• Imbalanced signaling pathways are implicated in BPD pathogenesis.
• These findings pave the way for novel therapeutic strategies for BPD prevention and management.